Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Gynecologic Oncology|July 13, 2016
Patterns of distant metastases in vulvar cancerKatharina Prieske, Nicole Haeringer, Donata Grimm, et al.
Oncotarget|June 8, 2017
VEGF-C expression attributes the risk for lymphatic metastases to ovarian cancer patientsSascha Kuerti, Leticia Oliveira-Ferrer, Karin Milde-Langosch, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 23, 2015
Sexual activity and function after surgical treatment in patients with (pre)invasive vulvar lesionsDonata Grimm, Christine Eulenburg, Oliver Brummer, et al.
Expert Review of Anticancer Therapy|May 22, 2015
Systemic treatment of vulvar cancerSven Mahner, Katharina Prieske, Donata Grimm, et al.
European Journal of Microbiology & Immunology|February 6, 2019
Comparison of PapilloCheck and Linear Array to Detect and Differentiate Human Papillomaviruses in Cervical and Tonsillar Smears from Females with Cervical Intraepithelial LesionsDonata Grimm, Linn Woelber, Katharina Prieske, et al.
Geburtshilfe Und Frauenheilkunde|August 17, 2023
Impact of Introducing a PACU24 Concept on the Perioperative Outcome of Patients with Advanced Ovarian Cancer Treated with Cytoreductive SurgerySusanne Reuter, Barbara Schmalfeldt, Sebastian A Haas, et al.
British Journal of Cancer|January 13, 2016
E-Cadherin fragments as potential mediators for peritoneal metastasis in advanced epithelial ovarian cancerFabian Trillsch, Sascha Kuerti, Christine Eulenburg, et al.
Molecular Oncology|October 3, 2021
BRCA1 promoter hypermethylation on circulating tumor DNA correlates with improved survival of patients with ovarian cancerMaha Elazezy, Katharina Prieske, Lan Kluwe, et al.
Annals of Surgical Oncology|February 10, 2016
The Risk of Contralateral Non-sentinel Metastasis in Patients with Primary Vulvar Cancer and Unilaterally Positive Sentinel NodeLinn Woelber, Christine Eulenburg, Donata Grimm, et al.
Oncogene|June 10, 2014
TRAIL-R2-specific antibodies and recombinant TRAIL can synergise to kill cancer cellsMark H Tuthill, Antonella Montinaro, Julia Zinngrebe, et al.
Pageof 5